Applied Nutrition is on a mission to become the world's most trusted sports brand
Prior Authorization Incomplete / Missing Documentation What it looks like: "Insufficient information," "missing documentation," "clinical records not provided." What to do: Contact your prescriber's office to find out exactly what was submitted
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management in adults (Mounjaro) and chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity (Zepbound)
The FDA Prescribing Information provides specific guidance on how to proceed based on how much time has elapsed since your scheduled injection day
If you have an autoimmune disease, obesity, diabetes, high cholesterol, or heart concerns, do not wait until symptoms become serious
2 Long-term cardiovascular outcomes data wont be available until TRIUMPH-CVOT reports, likely in 2028 at the earliest